Phase I/IIa trial of antibody-inducing peptide FPP-003 begins in Australia April 17, 2019 No Comments
Mallinckrodt, Washington University to jointly search for drugs targeting chronic itch April 12, 2019 No Comments
Patient enrollment ongoing in phase II study of KPL-716 in subjects with prurigo nodularis March 26, 2019 No Comments
RSS